309 related articles for article (PubMed ID: 38003333)
21. Developments of specialized pro-resolving mediators in periodontitis.
Liu YC
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
[TBL] [Abstract][Full Text] [Related]
22. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
23. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
24. Specialized pro-resolving mediators in respiratory diseases.
Cagnina RE; Duvall MG; Nijmeh J; Levy BD
Curr Opin Clin Nutr Metab Care; 2022 Mar; 25(2):67-74. PubMed ID: 34954726
[TBL] [Abstract][Full Text] [Related]
25. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
26. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
27. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
[TBL] [Abstract][Full Text] [Related]
28. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
Calder PC
Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
[TBL] [Abstract][Full Text] [Related]
29. Fish Oil Improves Pathway-Oriented Profiling of Lipid Mediators for Maintaining Metabolic Homeostasis in Adipose Tissue of Prediabetic Rats.
Dasilva G; Lois S; Méndez L; Miralles-Pérez B; Romeu M; Ramos-Romero S; Torres JL; Medina I
Front Immunol; 2021; 12():608875. PubMed ID: 33968013
[TBL] [Abstract][Full Text] [Related]
30. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
Zahoor I; Giri S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
[TBL] [Abstract][Full Text] [Related]
31. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer.
Babar MU; Nassar AF; Nie X; Zhang T; He J; Yeung J; Norris P; Ogura H; Muldoon A; Chen L; Libreros S
Metabolites; 2024 May; 14(6):. PubMed ID: 38921449
[TBL] [Abstract][Full Text] [Related]
32. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
[TBL] [Abstract][Full Text] [Related]
33. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
Duvall MG; Levy BD
Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
[TBL] [Abstract][Full Text] [Related]
34. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
Ji RR
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
[TBL] [Abstract][Full Text] [Related]
35. Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis.
Li W; Xia Y; Yang J; Sanyal AJ; Shah VH; Chalasani NP; Yu Q
medRxiv; 2023 Dec; ():. PubMed ID: 38168393
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 Fatty Acid Supplementation, Pro-Resolving Mediators, and Clinical Outcomes in Maternal-Infant Pairs.
Nordgren TM; Anderson Berry A; Van Ormer M; Zoucha S; Elliott E; Johnson R; McGinn E; Cave C; Rilett K; Weishaar K; Maddipati SS; Appeah H; Hanson C
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30621269
[TBL] [Abstract][Full Text] [Related]
37. Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.
Noureddine N; Hartling I; Wawrzyniak P; Srikanthan P; Lou PH; Lucchinetti E; Krämer SD; Rogler G; Zaugg M; Hersberger M
Am J Clin Nutr; 2022 Sep; 116(3):786-797. PubMed ID: 35849016
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
39. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
[TBL] [Abstract][Full Text] [Related]
40. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
